Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Core Scientific (CORZ) Non-Current Deffered Revenue (2021 - 2026)

Core Scientific has reported Non-Current Deffered Revenue over the past 3 years, most recently at $434.7 million for Q1 2026.

Quarterly results put Non-Current Deffered Revenue at $434.7 million for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $434.7 million (changed N/A YoY), and the annual figure for FY2025 was $428.3 million, changed.
Non-Current Deffered Revenue reached $434.7 million in Q1 2026 per CORZ's latest filing, up from $428.3 million in the prior quarter.
Across five years, Non-Current Deffered Revenue topped out at $434.7 million in Q1 2026 and bottomed at $428.3 million in Q4 2025.